Rose Wilson, A.A.-C. Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, G2-67, Washington, DC 20010 Phone: 202-877-7500 |
Daryl Jacob, CAA Anesthesiologist Assistant Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 888-884-2327 |
Arthur Ke Jr., AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1150 Varnum Street, Ne, Washington, DC 20017 Phone: 202-854-4041 Fax: 202-854-4034 |
Mr. Douglas Anthony Blakely, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 900 23rd St Nw, Washington, DC 20037 Phone: 202-715-4750 |
Mr. Daniel Joseph Pistone, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 202-877-7504 |
Megan Hawranick, C-AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 855-546-1686 |
Samuel Patrick Lind, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2150 Pennsylvania Ave Nw Ste 10-407, Washington, DC 20037 Phone: 202-715-5213 |
Andres Martinez-marin, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 900 23rd St Nw, Washington, DC 20037 Phone: 202-715-4750 |
Alex Steed, Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5000 |
News Archive
Though they remain a leading killer, heart attacks can be effectively treated provided they can be rapidly diagnosed following initial onset of symptoms. In a study appearing in this month's Molecular and Cellular Proteomics, researchers have identified cardiac myosin-binding protein C (cMyBP-C) as a potential new diagnostic biomarker for heart attacks, one that may be particularly valuable for mild attacks in which traditional diagnostic proteins may not be abundant enough.
GeneGo, Inc., the leading systems biology tools company, announced today that they will be launching a new web site with FREE high quality pathway content. On www.genego.com, anyone can now search for genes, proteins, compounds, processes and diseases and access high quality manually curated pathway maps for human, mouse and rat signaling and metabolism.
Enzon Pharmaceuticals, Inc. today announced that the first patient has been treated in the Phase 1 study of PEG-SN38 for pediatric cancer patients. PEG-SN38 or EZN-2208 is Enzon's PEGylated form of SN38, the active metabolite of the cancer drug Camptosar® (irinotecan HCl injection). The study is designed to find the recommended dose of PEG-SN38 in pediatric patients. The PEG-SN38 compound is currently being evaluated in Phase 2 studies for metastatic colorectal and breast cancer.
​The human body is daily exposed to external assaults such as bacteria, ultraviolet light or chemical agents. Skin, the largest organ of the body, is the first line of defense against these agents.
The recent survey you ask about was conducted by the MS Trust in 2012. It revealed that nearly one fifth of respondents had seen neither an MS specialist nurse (MSSN) nor a neurologist in the past year, and so will not have received the comprehensive annual review recommended by the National Institute for Health and Care Excellence (NICE).
› Verified 7 days ago